Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5601_Библиотеки_им_академика_М_И_Перельмана
.pdf
Subject Index Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 209
Carbonic anhydrase 186
Cardiac disease 60
Cardiovascular 2, 4, 23, 30, 49, 117, 118, 119,
124, 125, 128, 129, 134, 139, 146, 155,
157, 179
benefits 128, 129, 134, 146
disease 2, 4, 23, 30, 49, 118, 119, 125, 128,
139, 157
events 117, 124, 128, 134, 155, 157
toxicity 179
Children depression inventory (CDI) 81, 88,
90, 93
Cholecystectomy 182
Cholecystitis 182
Cholelithiasis 182
Cholesterol synthesis, compound inhibiting
148
Chronic 49, 120, 123, 124, 126, 130, 132, 168,
171, 173, 174, 175, 176, 177, 178, 188,
189
hyperglycemia 49, 174, 175, 176
kidney disease (CKD) 120, 123, 124, 126,
130, 132, 168, 171, 173, 174, 177, 178,
188, 189
CNS-dependent pathways 39
Combination therapy 133
Concomitant kidney disease 130
Conditions 11, 23, 30, 35, 40, 173, 176, 182,
187
complicated metabolic 23
reducing hyperglycemic 30
Connective tissue growth factor (CTGF) 175,
176
Conventional insulin delivery systems 37
Coptischinensis 33
Coronary 7, 118, 124, 125, 149, 150, 152
artery disease 7
heart disease (CHD) 118, 124, 125, 149,
150, 152
Cytokines 175, 176, 190
fibrogenic 175
pro-inflammatory 176, 190
D
Deaths 130, 150
cardiovascular 130
vascular 150
Diabetes 2, 3, 7, 9, 11, 22, 24, 31, 34, 36, 37,
38, 39, 40, 59, 68, 73, 75, 79, 80, 85, 86,
87, 88, 90, 94, 96, 139, 142
adherence questionnaire (DAQ) 59, 75, 80,
85, 86, 87, 88, 90, 94, 96
-associated complications 7
care 24, 31, 37, 39, 68, 90
drugs 24
family behavior checklist (DFBC) 79
gestational 11
pathogenesis 3, 7, 34
self-management 37, 73
treatment 22, 24, 36, 37, 38, 40, 139, 142
Diabetic 4, 25, 168, 169, 170, 171, 172, 174,
175, 189
atherosclerosis 4
disease 25
kidney disease (DKD) 168, 169, 170, 171,
172, 174, 175, 189
Diarrhea 33, 81, 92, 99, 145, 181, 183, 186,
191
Diet 51, 60, 61, 66, 68, 70, 71, 75, 76, 77, 94,
95, 177, 178, 182
high-fat 51, 177
nutritious 68
Disease 3, 6, 134
pathogenesis 3
process 134
progression 6
Disorders 1, 39, 40, 49, 117, 193
lipodystrophic 193
metabolic 1, 39, 49
sleep 193
Distress, psychosocial 72
Dizzyness 92
Drug binding affinity 7
Dynamic light scattering (DLS) 6
210 Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 Shazia Anjum
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Dysfunction 11, 121, 122, 135, 136, 169, 174,
177, 186
associated glomerular barrier 177
cognitive 186
endothelial 169
hemodynamic 174
renal 121, 122, 135, 136
thyroid 11
Dyslipidemia 33, 140, 148, 157, 169
atherogenic 169
E
Eating disorders 69
Effects, kidney-protective 177
Electron microscopy 174
Electrophoresis 6
Emotional feedback (EF) 59, 80, 85, 86, 87,
88, 89, 90, 91, 92, 93, 96, 102, 105
Endothelial nitric oxide synthase 193
End-stage kidney disease (ESKD) 130, 169,
170, 171, 189
Energy expenditure 177, 178
Energy intake 178
nutritional 178
Energy metabolism 129, 193
myocardial 129
Enzymes 12, 26, 27, 33, 128
intestinal 128
ketamine oxidase 12
lipid metabolism 33
malic 26
metabolic 27
Epithelial-to-mesenchymal transition 175
European 11, 24, 49, 52, 185, 186
association for the study of diabetes
(EASD) 11, 24
food safety authority (EFSA) 49, 52
medicines agency (EMA) 185, 186
F
Factors 52, 65, 66, 67, 69, 70, 75, 76, 77, 78,
79, 80, 102, 103, 172, 175, 141
adipocyte-derived 52
epigenetic 172
inflammatory 175
risk-enhancing 141
Fatty acyl-CoA synthase 25
Fibrosis 175, 176, 177
Fluorescence spectroscopy 6
Food 49, 50
consumption 49
dietary 50
Free fatty acids (FFAs) 26, 30, 52, 176, 177
Function 27, 32, 51
abnormal hepatocellular 51
antioxidant 32
renal 27
G
Gas chromatography-mass spectrometry
(GCMS) 6
Gastric inhibitory polypeptide (GIP) 30, 180,
190
Gastrointestinal 128, 180, 187, 192
disorders 192
endoscopic devices 187
system 128, 180
Gastrojejunostomy 187
Genetics 172
of kidneys in diabetes 172
of nephropathy 172
Genome-wide association studies (GWAS)
172
Glomerular 7, 174, 175, 177, 189
basement membrane (GBM) 174, 177
capillaries, renal 7
feedback 177
hyperfiltration 174, 175, 189
Glucoregulatory 38, 51
dysfunctions 38
response 51
Subject Index Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 211
Glucose 2, 3, 4, 6, 7, 10, 11, 24, 26, 32, 33,
34, 50, 51, 128, 131, 133, 175, 176, 177
absorption of 33, 34, 128
fasting serum 32
homeostasis 50, 51
metabolism 7, 51, 133
transporters 26, 176
Glucosuria 1
Glucosylation 1
Glutamic acid decarboxylase (GAD) 9
Glycated proteins 3, 6, 8, 9, 10
Glycogenolysis 30, 51
hepatic 30
Glycolysis 177
Glycopeptides 31
Glycosuria 28, 184
Gut 50, 51
microbes 50
microbiota 51
H
Healthy children and adolescents 77
Hemoglobin-related disease 11
Hemolytic anemia 10
Hepatic dysfunction 51
Hepatotoxicity 145
High 6, 12, 128
performance liquid chromatography
(HPLC) 6, 12
risk for cardiovascular disease 128
HMG-CoA reductase 148
Human serum albumin (HSA) 1, 2, 3, 4, 5, 6
Hyperfiltration 169, 188
Hyperglycaemia 3
Hyperglycemia 1, 3, 22, 23, 27, 34, 146, 174,
175, 176
Hyperinsulinemia 28, 169, 176, 177
Hyperperfusion 175
Hypoglycemia 26, 27, 28, 30, 34, 51, 68, 69,
123, 143, 144, 170
diabetic 26
hyperinsulinemic 28
symptomatic 34, 123, 144
Hypoglycemic 23, 50, 51
risk 23
pituitary-adrenal (HPA) 50, 51
I
Immune 4, 8, 9, 13, 36, 154
response 4, 8, 9, 13
system 8, 36, 154
Immunoassays 6, 12
electrochemical 12
enzyme-linked boronate 12
Inflammation 9, 177
chronic 9
hepatic 177
reaction 9
Inflammatory diseases 64
Infrared spectroscopy 6
Infusion, intravenous glucose 180
Inhibition assay 9
Inhibitors 22, 24, 29, 117, 120, 124, 131, 133,
145, 151, 170, 179, 186, 193
alpha-glucosidase 22, 24, 117, 124, 145, 179
gastric lipase 193
monoamine oxidase 186
renin-angiotensin system 170
Insomnia 50, 186
Insulin 1, 2, 3, 24, 26, 28, 29, 34, 35, 36, 39,
49, 51, 53, 61, 65, 66, 70, 71, 72, 75, 95,
133, 142, 144, 145, 180, 192
absorption 29
granule exocytosis 26
injections 24, 39, 61, 70, 144
pathways 53
response 133, 180
therapy 28, 66, 145
tolerance 26
treatment 65, 66, 70, 71, 72
Insulin resistance 24, 35, 50, 51, 52, 169, 173,
185, 188
production 51
Insulin secretion 1, 27, 28, 32, 133, 180, 181
pancreatic 181
Insulin sensitivity 7, 31, 50, 177, 178
212 Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 Shazia Anjum
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
adipocyte 7
Ion-exchange chromatography 12
Iron deficiency 10
Ischemic 141, 155
disease 141
heart disease 155
Islet 9, 24
cytoplasm 9
neogenesis 24
K
Ketoacidosis 28, 68
diabetic 28
Kidney 23, 168, 171, 173, 174, 175, 176, 177,
183, 188, 189, 190
failure 168
fibrosis 177
function 23, 171, 173, 188
impairment 176, 183
inflammation 176
injury 175, 176
outcomes 190
parenchyma 174
proximal tubule cells (KPTCs) 177
-related outcomes 173
transcriptomic response 189
transplantation 189
Kidney disease 28, 168, 169, 170, 171, 173,
177, 178, 179, 180, 181, 187, 189
diabesity-related 168
diabetic 168, 169, 171
global outcomes (KDIGO) 170
non-diabetic 170
L
Lipid 7, 26
metabolism 26
peroxidation 7
Lipid accumulation 173, 177
ectopic 173, 177
hepatic 177
Lipohypertrophy 29
Lipolysis 33, 177
Liquid chromatography 6, 12
high-performance 6, 12
-mass spectrometry 6
Liver 11, 26, 50, 177, 181
cirrhosis 11
enzymes 181
failure 26
function 50
injury 177
Low-density lipoproteins 2, 3, 4
M
Macrovascular disease 124
Management, glycemic 37
MAP-kinase pathways 7
Mass spectrometry 6
liquid chromatography-tandem 6
Mechanisms 25, 29, 30, 33, 148, 152, 173,
174, 177, 184, 185, 188, 189, 190
glucose-dependent 30
metabolic compensatory 184
Mediators, inflammatory 173
Medications 24, 25, 27, 28, 39, 67, 70, 117,
118, 119, 122, 137, 139, 157, 179, 180,
184, 185, 186
anti-diabetes 119, 139, 180
cardioprotective 118
cardiovascular 137
hyperlipidemia 117
immunosuppressive 39
lipid-lowering 118, 157
Medicinal plants 31
antidiabetic 31
Medicine 22, 24, 26
anti-diabetic 26
glucose-reducing 22
hypoglycemic 24
Medullary thyroid carcinoma 181
Mental 64, 73, 93, 100, 101, 104
health factors 73, 93, 100, 101
hygiene 104
Subject Index Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 213
transformation 64
Mesenchymal stem cell (MSCs) 35
Metabolic 169, 176, 186, 187
acidosis 186
complications 187
syndrome 169, 176
Metabolism 11, 27, 128, 134
abnormal haemoglobin 11
hepatic drug 27
myocardial 134
Metformin intolerance 27
Methamphetamine 179
Methicillinin Staphylococcus aureus 33
Methods 12
electrochemical 12
enzymatic 12
Microangiopathy 7
Microvascular 68, 169, 170
complications 68, 170
damage 169
Mortality 117, 118, 124, 127, 128, 130, 131,
136, 137, 139, 143, 146, 148, 187, 188
cardiovascular 118, 124, 127, 130
Myocardial infarction, acute 118
N
Nausea 181, 183, 186, 191
Nephritic syndrome 170
Nephrolithiasis 173, 186
Nephropathy 2, 4, 11, 49, 124, 169, 172
diabetic 4, 124, 169
Nephrotic syndrome 11
Neurological disease 50
NMR spectroscopy 6
Non-alcoholic fatty liver disease (NAFLD)
177
O
Oral glucose tolerance test (OGTT) 11
Oxidative stress 5, 173, 175, 176, 177
P
Pancreas 2, 29, 49, 50, 52, 142, 181
canine 142
Pancreatic lipases 185
Pancreatitis 139, 181, 182, 183
necrotizing 181
Pathways 7, 148, 174
biosynthesis 148
cellular signaling 7
epigenetic 174
metabolic 174
Peroxisome proliferator-activated receptors
(PPAR) 25, 26, 145
Piper nigrum 32
Plasma 4, 27, 118
glucose 118
proteins 4, 27
Problem(s) 23, 39, 40, 79, 81, 82, 193
coronary 39
heart 40
microvascular 23
neuromuscular 82
public health 39, 193
recognition and illness self-management
(PRISM) 79
social behaviour 81
Process 5, 37, 65, 66, 175, 177
flexible self-management 66
inflammatory 175
Production 3, 4, 7, 24, 36, 51, 142, 173, 175,
176, 193
hepatic glucose 51
nitric oxide 193
oxidant 176
Pro-inflammatory signaling 177
Protein(s) 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 49
autologous 4
glycation 1, 6
lysine-rich 5
metabolism 1, 49
non-enzymatic glycation of 1, 4
transmembrane 7
214 Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 Shazia Anjum
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Protein kinase 33, 175
monophosphate-activated 33
C (PKC) 175
Proteinuria 188, 190
R
Reactive 4, 7, 52, 175
nitrogen species (RNS) 52
oxygen species (ROS) 4, 7, 52, 175
Regulation 5, 32
hepatic glycolysis 32
oncotic pressure 5
Renal 11, 124, 129, 130
affection 130
disease 124
impairment 11
-protection 129
Renin-angiotensin-aldosterone system
(RAAS) 173, 175
Researching cardiovascular events 125
Residues 2, 4, 9
glycated-lysine 9
histidine 2
Retinopathy 2, 4, 7, 11, 39, 49, 137, 170, 184
diabetic 4, 7, 137, 170
Revascularization, coronary 153
Risk factors 51, 143
cardiometabolic 51
cardiovascular 143
S
Self-rated health (SRH) 62, 64, 81, 84, 92, 99,
100, 101
Strengths and difficulties questionnaire (SDQ)
83, 88, 90, 91, 92, 93
Stroke 118, 119, 120, 121, 122, 123, 124, 126,
127, 129, 130, 134, 135, 136, 137, 138,
146, 149, 150, 156
Sweeteners 48, 49, 50, 51, 53
artificial 48, 50
caloric 51
natural 49, 50
T
Therapies 34, 37
immune-modulatory 34
stem cell transplant 37
Thiazolidinediones 22, 24, 25, 27, 117, 124,
145, 179, 184
Thrombolysis 124
Transplantation 35, 36, 39, 120, 132, 189
renal 120, 132
Transporters, electrolyte 129
Tumor necrosis factor 175
U
US preventive services task force (USPSTF)
179
V
Vascular 24, 122, 150, 151
disease 24, 150, 151
pathology 122
Vascular events 127, 139, 149, 150, 155
adverse 139
severe 155
Vasoconstriction 175
Vasoconstrictor, reducing 177
Vertical sleeve gastrectomy (VSG) 187, 188
Visceral fat secretory biology 24
Visual analogue scale 82
Vitamins 185, 187
deficiencies 187
fat-soluble 185
Vomiting 181, 183, 186, 191
W
World health organization (WHO) 31
Subject Index Frontiers in Clinical Drug Research-Diabetes & Obesity, Vol. 7 215
Z
Zucker diabetic fatty (ZDF) 189
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Соседние файлы в папке Библиотека им академика М.И. Перельмана